XD9E:XETRA:XETRA-Xtrackers MSCI USA UCITS ETF 2C - EUR Hedged (EUR)

ETF | Others |

Last Closing

USD 112.415

Change

+0.86 (+0.77)%

Market Cap

USD 0.27B

Volume

435.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.23 (-0.43%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.06 (-0.36%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.18 (-0.64%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.11 (-0.37%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.01 (-0.02%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.88 (+0.62%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

-0.21 (-0.45%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.13 (-0.26%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.32 (+0.33%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+2.04 (+0.37%)

USD 80.38B

ETFs Containing XD9E:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.56% 81% B- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.56% 81% B- 79% B-
Trailing 12 Months  
Capital Gain 23.06% 81% B- 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.06% 81% B- 80% B-
Trailing 5 Years  
Capital Gain 76.60% 88% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 76.60% 87% B+ 84% B
Average Annual (5 Year Horizon)  
Capital Gain 12.84% 83% B 80% B-
Dividend Return 12.84% 83% B 79% B-
Total Return N/A 87% B+ 73% C
Risk Return Profile  
Volatility (Standard Deviation) 19.13% 22% F 35% F
Risk Adjusted Return 67.10% 75% C 77% C+
Market Capitalization 0.27B 53% F 47% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.